Copyright Reports & Markets. All rights reserved.

Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Receptor Tyrosine Protein Kinase Targeted Drugs

      • 1.1 Definition of Receptor Tyrosine Protein Kinase Targeted Drugs
      • 1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type
        • 1.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Afatinib Dimaleate
        • 1.2.3 Dacomitinib
        • 1.2.4 Neratinib
        • 1.2.5 Neucardin
        • 1.2.6 Others
      • 1.3 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Applications
        • 1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Cardiovascular
        • 1.3.4 Central Nervous System
        • 1.3.5 Others
      • 1.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Overall Market
        • 1.4.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (2014-2025)
        • 1.4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production (2014-2025)
        • 1.4.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
      • 2.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs
      • 2.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase Targeted Drugs

      3 Development and Manufacturing Plants Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Receptor Tyrosine Protein Kinase Targeted Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Production and Capacity Analysis
      • 4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Analysis
      • 4.3 Receptor Tyrosine Protein Kinase Targeted Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Receptor Tyrosine Protein Kinase Targeted Drugs Regional Market Analysis

      • 5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Production by Regions
        • 5.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production by Regions
        • 5.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions
      • 5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Regions
      • 5.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.3.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export
      • 5.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.4.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export
      • 5.5 China Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.5.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.5.2 China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export
      • 5.6 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.6.1 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.6.2 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export
      • 5.7 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.7.1 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.7.2 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export
      • 5.8 India Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis
        • 5.8.1 India Receptor Tyrosine Protein Kinase Targeted Drugs Production
        • 5.8.2 India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Receptor Tyrosine Protein Kinase Targeted Drugs Import and Export

      6 Receptor Tyrosine Protein Kinase Targeted Drugs Segment Market Analysis (by Type)

      • 6.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production by Type
      • 6.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type
      • 6.3 Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type

      7 Receptor Tyrosine Protein Kinase Targeted Drugs Segment Market Analysis (by Application)

      • 7.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption by Application
      • 7.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Consumption Market Share by Application (2014-2019)

      8 Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers Analysis

      • 8.1 Aslan Pharmaceuticals Pte Ltd
        • 8.1.1 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.1.2 Aslan Pharmaceuticals Pte Ltd Product Introduction, Application and Specification
        • 8.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Boehringer Ingelheim GmbH
        • 8.2.1 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.2.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
        • 8.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GamaMabs Pharma SA
        • 8.3.1 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.3.2 GamaMabs Pharma SA Product Introduction, Application and Specification
        • 8.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Hanmi Pharmaceuticals Co Ltd
        • 8.4.1 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.4.2 Hanmi Pharmaceuticals Co Ltd Product Introduction, Application and Specification
        • 8.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Jiangsu Kanion Pharmaceutical Co Ltd
        • 8.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Product Introduction, Application and Specification
        • 8.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Minerva Neurosciences Inc
        • 8.6.1 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.6.2 Minerva Neurosciences Inc Product Introduction, Application and Specification
        • 8.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Pfizer Inc
        • 8.7.1 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.7.2 Pfizer Inc Product Introduction, Application and Specification
        • 8.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Puma Biotechnology Inc
        • 8.8.1 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.8.2 Puma Biotechnology Inc Product Introduction, Application and Specification
        • 8.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        • 8.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Product Introduction, Application and Specification
        • 8.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 XuanZhu Pharma Co Ltd
        • 8.10.1 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production Sites and Area Served
        • 8.10.2 XuanZhu Pharma Co Ltd Product Introduction, Application and Specification
        • 8.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Zensun (Shanghai) Sci & Tech Co Ltd

      9 Development Trend of Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs Market

      • 9.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Trend Analysis
        • 9.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Regional Market Trend
        • 9.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
        • 9.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
        • 9.2.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
        • 9.2.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
        • 9.2.6 India Receptor Tyrosine Protein Kinase Targeted Drugs Forecast 2019-2025
      • 9.3 Receptor Tyrosine Protein Kinase Targeted Drugs Market Trend (Product Type)
      • 9.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Receptor Tyrosine Protein Kinase Targeted Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Receptor Tyrosine Protein Kinase Targeted Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Receptor Tyrosine Protein Kinase Targeted Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Receptor Tyrosine Protein Kinase Targeted Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Receptor Tyrosine Protein Kinase Targeted Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Receptor Tyrosine Protein Kinase Targeted Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Aslan Pharmaceuticals Pte Ltd
        Boehringer Ingelheim GmbH
        GamaMabs Pharma SA
        Hanmi Pharmaceuticals Co Ltd
        Jiangsu Kanion Pharmaceutical Co Ltd
        Minerva Neurosciences Inc
        Pfizer Inc
        Puma Biotechnology Inc
        Shanghai Fosun Pharmaceutical (Group) Co Ltd
        XuanZhu Pharma Co Ltd
        Zensun (Shanghai) Sci & Tech Co Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Afatinib Dimaleate
        Dacomitinib
        Neratinib
        Neucardin
        Others

        Segment by Application
        Oncology
        Cardiovascular
        Central Nervous System
        Others

        Buy now